We are live on ! Find out more
ACM

AlphaCrest Capital Management Portfolio holdings

AUM $1.64B
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
+4.34%
1 Year Est. Return
-23.4%
3 Year Est. Return
-8.44%
5 Year Est. Return
10 Year Est. Return
AUM
$2.33B
AUM Growth
+$532M
Cap. Flow
+$466M
Cap. Flow %
20.05%
Top 10 Hldgs %
5.87%
Holding
1,402
New
244
Increased
583
Reduced
375
Closed
199

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$17.3M
2
NKE icon
Nike
NKE
+$16.2M
3
MRK icon
Merck
MRK
+$13.4M
4
CMCSA icon
Comcast
CMCSA
+$12.8M
5
MSFT icon
Microsoft
MSFT
+$9.26M

Sector Composition

Rank Sector Weight
1 Technology 19.18%
2 Financials 14.64%
3 Healthcare 14.37%
4 Industrials 13.29%
5 Consumer Discretionary 10.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
801
GE Aerospace
GE
$378B
$730K 0.03%
10,880
+6,877
+172% +$459K
ADT icon
802
ADT
ADT
$5.74B
$725K 0.03%
67,147
-44,153
-40% -$444K
SR icon
803
Spire
SR
$4.76B
$724K 0.03%
10,013
+1,411
+16% +$105K
ATI icon
804
ATI
ATI
$25.8B
$721K 0.03%
+34,600
New +$793K
CINF icon
805
Cincinnati Financial
CINF
$27.2B
$721K 0.03%
6,184
-5,258
-46% -$607K
TVTX icon
806
Travere Therapeutics
TVTX
$5.07B
$721K 0.03%
+49,400
New +$974K
APA icon
807
APA Corp
APA
$13.2B
$720K 0.03%
33,300
+15,245
+84% +$313K
WKC icon
808
World Kinect Corp
WKC
$2.02B
$720K 0.03%
22,695
+6,191
+38% +$206K
FTS icon
809
Fortis
FTS
$28.9B
$718K 0.03%
16,239
+11,339
+231% +$511K
EXP icon
810
Eagle Materials
EXP
$6.52B
$716K 0.03%
+5,036
New +$724K
QVCGA
811
DELISTED
QVC Group Inc Series A
QVCGA
$715K 0.03%
1,093
-3,303
-75% -$2.12M
RVMD icon
812
Revolution Medicines
RVMD
$39.1B
$714K 0.03%
+22,500
New +$785K
CW icon
813
Curtiss-Wright
CW
$27.3B
$713K 0.03%
6,000
-2,483
-29% -$311K
PFGC icon
814
Performance Food Group
PFGC
$17.8B
$713K 0.03%
+14,702
New +$776K
DCI icon
815
Donaldson
DCI
$11B
$712K 0.03%
11,208
-26,500
-70% -$1.64M
BF.B icon
816
Brown-Forman Class B
BF.B
$12.9B
$710K 0.03%
9,468
-29,185
-76% -$2.22M
SSB icon
817
SouthState Bank Corp
SSB
$10.3B
$709K 0.03%
8,668
-5,492
-39% -$467K
HR
818
DELISTED
Healthcare Realty Trust Incorporated
HR
$709K 0.03%
+23,491
New +$732K
EAF icon
819
GrafTech
EAF
$185M
$706K 0.03%
6,077
+617
+11% +$77.4K
NATI
820
DELISTED
National Instruments Corp
NATI
$703K 0.03%
16,621
+4,786
+40% +$202K
STMP
821
DELISTED
Stamps.com, Inc.
STMP
$703K 0.03%
3,512
+2,200
+168% +$431K
ROST icon
822
Ross Stores
ROST
$81.1B
$702K 0.03%
5,662
-1,405
-20% -$175K
UMPQ
823
DELISTED
Umpqua Holdings Corp
UMPQ
$702K 0.03%
38,034
+14,248
+60% +$265K
SLB icon
824
SLB Ltd
SLB
$73.5B
$699K 0.03%
+21,822
New +$670K
VRT icon
825
Vertiv
VRT
$99.2B
$699K 0.03%
25,620
-36,880
-59% -$882K

Similar funds

AlphaCrest Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, AlphaCrest Capital Management held 1,402 positions worth $2.33B, up 30% from $1.79B the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.

AlphaCrest Capital Management deployed $466M of net new capital in Q2 2021, opening 244 new positions and adding to 583 existing holdings. Its largest new stake was Nucor: 85,982 shares worth $8.25M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Morgan Stanley, an estimated $17.3M trimmed.

  • AlphaCrest Capital Management's largest Q2 2021 buy was Nucor: 85,982 shares worth $8.25M.
  • AlphaCrest Capital Management added most to Fiserv Inc in Q2 2021, an estimated $12.3M increase.
  • AlphaCrest Capital Management's biggest Q2 2021 reduction was Morgan Stanley, cutting an estimated $17.3M.
  • AlphaCrest Capital Management fully exited Merck in Q2 2021, selling an estimated $13.4M.
  • AlphaCrest Capital Management's ten largest holdings make up 5.9% of its $2.33B portfolio in Q2 2021.
  • AlphaCrest Capital Management opened 244 new positions and closed 199 in Q2 2021.
  • AlphaCrest Capital Management's portfolio value rose 30% quarter-over-quarter to $2.33B.

Based on AlphaCrest Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.